docket_stats: 62890

Pre-computed view: comment and document counts per docket with date ranges. ⚠ HELD COUNTS ONLY (2026-09-04, queue #706): DataDawn holds ~41.5% of the regulations.gov comment corpus (9.86M of 23.7M, 2005–2026), and the missing records concentrate in mass-comment dockets, so any count is a FLOOR and any ranking by comment volume is biased AGAINST the highest-salience campaigns. Per agency-year holdings vs upstream: /explore/comments-coverage.html.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

rowid	id	agency_id	title	docket_type	comment_count	document_count	earliest_comment	latest_comment	earliest_document	latest_document
62890	FDA-2026-P-2353	FDA	Requests that the FDA declare that the drug products Progesterone Tablets, 150 mg and 300 mg, are suitable for consideration in an Abbreviated New Drug Application.	Nonrulemaking	0	9			2026-03-06T05:00:00Z	2026-08-28T04:00:00Z